1,418 results on '"Hillege, Hans L."'
Search Results
2. A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction
3. Predictors and outcomes of heart failure with mid‐range ejection fraction
4. Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease
5. Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure: Results from the PROTECT Trial
6. The Genetic Epidemiology of Pediatric Pulmonary Arterial Hypertension
7. Serial Measurements of N-Terminal Pro-B-Type Natriuretic Peptide Serum Level for Monitoring Pulmonary Arterial Hypertension in Children
8. Distinct Pathological Pathways in Patients With Heart Failure and Diabetes
9. 52 Genetic Loci Influencing Myocardial Mass
10. A combined clinical and biomarker approach to predict diuretic response in acute heart failure
11. Sex differences in patients with repaired tetralogy of Fallot support a tailored approach for males and females: a cardiac magnetic resonance study
12. Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration
13. A heart failure phenotype stratified model for predicting 1-year mortality in patients admitted with acute heart failure: results from an individual participant data meta-analysis of four prospective European cohorts
14. Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction
15. Patient Preferences in the Medical Product Lifecycle
16. Gene-Age Interactions in Blood Pressure Regulation: A Large-Scale Investigation with the CHARGE, Global BPgen, and ICBP Consortia
17. Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction
18. The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patients
19. Trajectories of renal biomarkers and new‐onset heart failure in the general population: Findings from the PREVEND study
20. Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction
21. The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF
22. Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure
23. Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHF
24. Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation
25. Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction
26. Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study
27. Serum Potassium Levels and Outcome in Acute Heart Failure (Data from the PROTECT and COACH Trials)
28. Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure — Post-hoc analysis of the PROTECT trial
29. Acute heart failure in the young: Clinical characteristics and biomarker profiles
30. Urinary Marker Profiles in Heart Failure with Reduced Versus Preserved Ejection Fraction
31. Transitions across Kidney Disease Stages and Association with New-onset Heart Failure: a Population-Based study of 8569 Individuals and 12.6 Years of Follow-up
32. Multimarker Analysis of Serially Measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, Creatinine, and Prognosis in Acute Heart Failure
33. Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patients
34. MicroRNAs relate to early worsening of renal function in patients with acute heart failure
35. Six-minute walking distance and decrease in oxygen saturation during the six-minute walk test in pediatric pulmonary arterial hypertension
36. Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failure
37. Clinical Worsening as Composite Study End Point in Pediatric Pulmonary Arterial Hypertension
38. Biochemical Validation of Patient-Reported Symptom Onset Time in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
39. Prognostic factors in pediatric pulmonary arterial hypertension: A systematic review and meta-analysis
40. European Medicines Agency review of ataluren for the treatment of ambulant patients aged 5 years and older with Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene
41. Should non-cardiovascular mortality be considered in the SCORE model? Findings from the Prevention of Renal and Vascular End-stage Disease (PREVEND) cohort
42. Antiarrhythmic drugs in patients with early persistent atrial fibrillation and heart failure: results of the RACE 3 study
43. A simulated maximum likelihood procedure for analyzing imprecise trade‐off thresholds between the benefits and harms of medicines
44. A multi-criteria decision analysis perspective on the health economic evaluation of medical interventions
45. Proteomic diversity of high‐density lipoprotein explains its association with clinical outcome in patients with heart failure
46. Pulmonary arterial stiffness indices assessed by intravascular ultrasound in children with early pulmonary vascular disease: prediction of advanced disease and mortality during 20-year follow-up
47. Relation of renal dysfunction with incident atrial fibrillation and cardiovascular morbidity and mortality: The PREVEND study
48. A network analysis to compare biomarker profiles in patients with and without diabetes mellitus in acute heart failure
49. Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT‐CHF
50. Cardiac Magnetic Resonance Derived Left Ventricular Eccentricity Index and Right Ventricular Mass Measurements Predict Outcome in Children with Pulmonary Arterial Hypertension.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.